Oberle, M. M., & Kelly, A. S. (2019). It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth. Front Endocrinol (Lausanne).
Citação norma ChicagoOberle, Megan M., and Aaron S. Kelly. "It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth." Front Endocrinol (Lausanne) 2019.
Citação norma MLAOberle, Megan M., and Aaron S. Kelly. "It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth." Front Endocrinol (Lausanne) 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.